Australia markets closed

Castle Biosciences, Inc. (CSTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
34.97-0.47 (-1.33%)
At close: 04:00PM EST
34.97 0.00 (0.00%)
After hours: 04:01PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
86,345
62,649
51,865
22,786
Cost of revenue
13,898
9,685
7,310
5,297
Gross profit
72,447
52,964
44,555
17,489
Operating expenses
Research development
24,782
13,256
7,385
4,854
Selling general and administrative
76,537
48,132
29,842
16,470
Total operating expenses
100,387
59,506
37,227
21,325
Operating income or loss
-27,940
-6,542
7,328
-3,836
Interest expense
395
2,634
4,571
2,274
Total other income/expenses net
-
-1,397
2,280
-272.417
Income before tax
-29,662
-10,200
5,349
-6,358
Income tax expense
89
84
72
8.606
Income from continuing operations
-29,751
-10,284
5,277
-6,367
Net income
-29,751
-10,284
5,277
-6,367
Net income available to common shareholders
-29,751
-10,284
2,991
-6,095
Basic EPS
-
-0.54
0.35
-0.62
Diluted EPS
-
-0.54
-0.21
-0.62
Basic average shares
-
18,929
8,584
9,784
Diluted average shares
-
18,929
8,658
9,784
EBITDA
-
-7,094
10,278
-3,762